Alkem Laboratories Q2 FY25 Financial Results Highlights:
- Revenue from Operations:
- Quarter-over-Quarter (QoQ): Revenue rose to ₹3,414.67 crore in Q2 FY25 from ₹3,031.82 crore in Q1 FY25.
- Year-over-Year (YoY): Revenue remained relatively stable compared to ₹3,440.17 crore in Q2 FY24.
- Net Profit:
- Quarter-over-Quarter (QoQ): The profit for the period increased significantly to ₹701.96 crore in Q2 FY25 from ₹550.24 crore in Q1 FY25.
- Year-over-Year (YoY): Net profit grew from ₹614.89 crore in Q2 FY24 to ₹701.96 crore in Q2 FY25.
Alkem Laboratories demonstrated consistent revenue and profit growth over the past year, driven by effective cost management and stable operational performance.
- Revenue from Operations:
- Year-over-Year (YoY): Revenue decreased slightly by 0.7%, from ₹3,440.17 crore in Q2 FY24 to ₹3,414.67 crore in Q2 FY25.
- Quarter-over-Quarter (QoQ): Revenue increased by 12.6%, from ₹3,031.82 crore in Q1 FY25 to ₹3,414.67 crore in Q2 FY25.
- Net Profit:
- Year-over-Year (YoY): Net profit grew by 14.2%, from ₹614.89 crore in Q2 FY24 to ₹701.96 crore in Q2 FY25.
- Quarter-over-Quarter (QoQ): Net profit increased by 27.6%, from ₹550.24 crore in Q1 FY25 to ₹701.96 crore in Q2 FY25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
TOPICS:
Alkem Laboratories